In the last 12 months, insiders at MapLight Therapeutics, Inc. ($MPLT) filed 154 transactions with the SEC: 6 open-market purchases totaling $109,393,835 and 93 sales totaling $17,527,940. Net insider sentiment: net buying.
MapLight Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Catalyst4, Inc. (Not found) — 8 transactions totaling $92,499,992
- Novo Holdings A/S (Not found) — 4 transactions totaling $16,199,997
- Kroeger Christopher A. (Chief Executive Officer) — 29 transactions totaling $10,768,561
- GILLIS JONATHAN (CAAO and PAO) — 11 transactions totaling $2,579,676
- Foff Erin Pennock (Chief Medical Officer) — 18 transactions totaling $2,443,288
View all SEC Filings for MapLight Therapeutics, Inc. (MPLT).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 198 | $28.15 | 1,394,094.0000 | 45,373,033 | 0.01% | 0.00% |
| May 18, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 118037 | $27.19 | 1,394,292.0000 | 45,373,033 | 7.80% | 0.26% |
| May 7, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5220 | $29.15 | 1,661,910.0000 | 45,373,033 | 0.31% | 0.01% |
| May 7, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 14880 | $28.47 | 1,667,130.0000 | 45,373,033 | 0.88% | 0.03% |
| May 11, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 5808 | $30.56 | 162,331.0000 | 45,373,033 | 3.45% | 0.01% |
| May 11, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 6979 | $30.04 | 168,139.0000 | 45,373,033 | 3.99% | 0.02% |
| May 11, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 846 | $28.70 | 175,118.0000 | 45,373,033 | 0.48% | 0.00% |
| May 11, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 284 | $27.61 | 175,964.0000 | 45,373,033 | 0.16% | 0.00% |
| May 7, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 721 | $28.28 | 242,729.0000 | 45,373,033 | 0.30% | 0.00% |
| May 7, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 117 | $29.10 | 346,059.0000 | 45,373,033 | 0.03% | 0.00% |
| May 7, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 4321 | $28.52 | 346,176.0000 | 45,373,033 | 1.23% | 0.01% |
| May 11, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5890 | $30.56 | 1,613,519.0000 | 45,373,033 | 0.36% | 0.01% |
| May 11, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 6871 | $30.04 | 1,619,409.0000 | 45,373,033 | 0.42% | 0.02% |
| May 11, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 877 | $28.70 | 1,626,280.0000 | 45,373,033 | 0.05% | 0.00% |
| May 11, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 342 | $27.57 | 1,627,157.0000 | 45,373,033 | 0.02% | 0.00% |
| May 8, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 1582 | $28.56 | 1,630,704.0000 | 45,373,033 | 0.10% | 0.00% |
| May 8, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 3205 | $29.20 | 1,627,499.0000 | 45,373,033 | 0.20% | 0.01% |
| May 8, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 29624 | $27.48 | 1,632,286.0000 | 45,373,033 | 1.78% | 0.07% |
| May 4, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 320 | $29.56 | 280,061.0000 | 45,373,033 | 0.11% | 0.00% |
| May 4, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 5526 | $28.37 | 280,381.0000 | 45,373,033 | 1.93% | 0.01% |
| May 4, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 9250 | $27.50 | 285,907.0000 | 45,373,033 | 3.13% | 0.02% |
| May 6, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 15900 | $29.13 | 350,497.0000 | 45,373,033 | 4.34% | 0.04% |
| May 6, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 8152 | $28.04 | 366,397.0000 | 45,373,033 | 2.18% | 0.02% |
| May 5, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 931 | $29.00 | 374,549.0000 | 45,373,033 | 0.25% | 0.00% |
| May 5, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 9645 | $28.12 | 375,480.0000 | 45,373,033 | 2.50% | 0.02% |
| May 4, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 700 | $30.08 | 385,125.0000 | 45,373,033 | 0.18% | 0.00% |
| May 4, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 312 | $29.56 | 385,825.0000 | 45,373,033 | 0.08% | 0.00% |
| May 4, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 5460 | $28.37 | 386,137.0000 | 45,373,033 | 1.39% | 0.01% |
| May 4, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 9180 | $27.50 | 391,597.0000 | 45,373,033 | 2.29% | 0.02% |
| May 6, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 2068 | $29.07 | 356,256.0000 | 45,373,033 | 0.58% | 0.00% |
| May 6, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 15603 | $29.13 | 1,682,010.0000 | 45,373,033 | 0.92% | 0.03% |
| May 6, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 8098 | $28.04 | 1,697,613.0000 | 45,373,033 | 0.47% | 0.02% |
| May 5, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 928 | $29.00 | 1,705,711.0000 | 45,373,033 | 0.05% | 0.00% |
| May 5, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9544 | $28.12 | 1,706,639.0000 | 45,373,033 | 0.56% | 0.02% |
| May 4, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 697 | $30.08 | 1,716,183.0000 | 45,373,033 | 0.04% | 0.00% |
| May 4, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 311 | $29.56 | 1,716,880.0000 | 45,373,033 | 0.02% | 0.00% |
| May 4, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 5427 | $28.37 | 1,717,191.0000 | 45,373,033 | 0.32% | 0.01% |
| May 4, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9136 | $27.50 | 1,722,618.0000 | 45,373,033 | 0.53% | 0.02% |
| May 4, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 683 | $30.08 | 176,248.0000 | 45,373,033 | 0.39% | 0.00% |
| May 4, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 296 | $29.56 | 176,931.0000 | 45,373,033 | 0.17% | 0.00% |
| May 4, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 3908 | $28.29 | 177,227.0000 | 45,373,033 | 2.16% | 0.01% |
| May 4, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 9030 | $27.50 | 181,135.0000 | 45,373,033 | 4.75% | 0.02% |
| May 6, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 16421 | $29.13 | 243,450.0000 | 45,373,033 | 6.32% | 0.04% |
| May 6, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 8390 | $28.04 | 259,871.0000 | 45,373,033 | 3.13% | 0.02% |
| May 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 963 | $29.00 | 268,261.0000 | 45,373,033 | 0.36% | 0.00% |
| May 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 10132 | $28.12 | 269,224.0000 | 45,373,033 | 3.63% | 0.02% |
| May 4, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 705 | $30.08 | 279,356.0000 | 45,373,033 | 0.25% | 0.00% |
| May 6, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 8496 | $28.04 | 358,324.0000 | 45,373,033 | 2.32% | 0.02% |
| May 5, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 968 | $29.00 | 366,820.0000 | 45,373,033 | 0.26% | 0.00% |
| May 5, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 9935 | $28.12 | 367,788.0000 | 45,373,033 | 2.63% | 0.02% |
| May 4, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 787 | $30.12 | 377,723.0000 | 45,373,033 | 0.21% | 0.00% |
| May 4, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 325 | $29.56 | 378,510.0000 | 45,373,033 | 0.09% | 0.00% |
| May 4, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 8989 | $28.28 | 378,835.0000 | 45,373,033 | 2.32% | 0.02% |
| May 4, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 4803 | $27.36 | 387,824.0000 | 45,373,033 | 1.22% | 0.01% |
| April 27, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 29623 | $29.60 | 213,517.0000 | 45,373,033 | 12.18% | 0.07% |
| April 27, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 7914 | $28.94 | 243,140.0000 | 45,373,033 | 3.15% | 0.02% |
| April 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | S | Voting Common Stock | 7821 | $30.50 | 211,190.0000 | 45,373,033 | 3.57% | 0.02% |
| April 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | S | Voting Common Stock | 29255 | $29.63 | 219,011.0000 | 45,373,033 | 11.78% | 0.06% |
| April 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | S | Voting Common Stock | 8346 | $28.96 | 248,266.0000 | 45,373,033 | 3.25% | 0.02% |
| April 28, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 700 | $30.83 | 181,219.0000 | 45,373,033 | 0.38% | 0.00% |
| April 28, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 17235 | $30.33 | 181,919.0000 | 45,373,033 | 8.65% | 0.04% |
| April 27, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 14363 | $30.46 | 199,154.0000 | 45,373,033 | 6.73% | 0.03% |
| April 16, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 225 | $27.49 | 190,165.0000 | 45,373,033 | 0.12% | 0.00% |
| April 15, 2026 | Kreitzer Anatol | Chief Discovery Officer | S | Voting Common Stock | 3316 | $26.61 | 256,612.0000 | 45,373,033 | 1.28% | 0.01% |
| April 15, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 1529 | $26.80 | 190,463.0000 | 45,373,033 | 0.80% | 0.00% |
| April 16, 2026 | Hanson Kristopher | General Counsel | S | Voting Common Stock | 73 | $27.01 | 190,390.0000 | 45,373,033 | 0.04% | 0.00% |
| April 15, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 2806 | $26.87 | 392,743.0000 | 45,373,033 | 0.71% | 0.01% |
| April 16, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 29 | $27.01 | 392,714.0000 | 45,373,033 | 0.01% | 0.00% |
| April 16, 2026 | Setia Vishwas | Chief Financial Officer | S | Voting Common Stock | 87 | $27.49 | 392,627.0000 | 45,373,033 | 0.02% | 0.00% |
| April 15, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 1730 | $26.82 | 297,940.0000 | 45,373,033 | 0.58% | 0.00% |
| April 16, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 686 | $27.01 | 297,254.0000 | 45,373,033 | 0.23% | 0.00% |
| April 16, 2026 | Lillie James Woodruff | Chief Scientific Officer | S | Voting Common Stock | 2097 | $27.49 | 295,157.0000 | 45,373,033 | 0.71% | 0.00% |
| April 15, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 2044 | $26.84 | 401,946.0000 | 45,373,033 | 0.51% | 0.00% |
| April 16, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 288 | $27.01 | 401,658.0000 | 45,373,033 | 0.07% | 0.00% |
| April 16, 2026 | Foff Erin Pennock | Chief Medical Officer | S | Voting Common Stock | 881 | $27.49 | 400,777.0000 | 45,373,033 | 0.22% | 0.00% |
| April 15, 2026 | GILLIS JONATHAN | CAAO and PAO | S | Voting Common Stock | 3590 | $26.61 | 251,054.0000 | 45,373,033 | 1.41% | 0.01% |
| April 15, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 9135 | $26.93 | 1,741,806.0000 | 45,373,033 | 0.52% | 0.02% |
| April 16, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 2477 | $27.01 | 1,739,329.0000 | 45,373,033 | 0.14% | 0.01% |
| April 16, 2026 | Kroeger Christopher A. | Chief Executive Officer | S | Voting Common Stock | 7575 | $27.49 | 1,731,754.0000 | 45,373,033 | 0.44% | 0.02% |
| April 15, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 8593 | $26.90 | 348,138.0000 | 45,373,033 | 2.41% | 0.02% |
| Feb. 23, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 10788 | $18.39 | 357,943.0000 | 45,373,033 | 2.93% | 0.02% |
| Feb. 23, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 476 | $19.06 | 357,467.0000 | 45,373,033 | 0.13% | 0.00% |
| Feb. 24, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 736 | $18.15 | 356,731.0000 | 45,373,033 | 0.21% | 0.00% |
| Feb. 20, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 2195 | $18.03 | 368,731.0000 | 45,373,033 | 0.59% | 0.00% |
| Feb. 18, 2026 | Pavlov George | Not found | P | Voting Common Stock | 10658 | $17.48 | 10,658.0000 | 45,373,033 | 9999.99% | 0.02% |
| Feb. 19, 2026 | Pavlov George | Not found | P | Voting Common Stock | 4422 | $17.57 | 15,080.0000 | 45,373,033 | 41.49% | 0.01% |
| Feb. 20, 2026 | Pavlov George | Not found | P | Voting Common Stock | 9920 | $17.86 | 25,000.0000 | 45,373,033 | 65.78% | 0.02% |
| Feb. 13, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 12116 | $18.21 | 370,926.0000 | 45,373,033 | 3.16% | 0.03% |
| Feb. 10, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 6622 | $18.12 | 383,283.0000 | 45,373,033 | 1.70% | 0.01% |
| Feb. 11, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 241 | $18.00 | 383,042.0000 | 45,373,033 | 0.06% | 0.00% |
| Feb. 10, 2026 | Garnett Timothy John | Not found | P | Voting Common Stock | 14124 | $17.89 | 63,649.0000 | 45,373,033 | 28.52% | 0.03% |
| Feb. 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 7730 | $0.00 | 298,862.0000 | 45,373,033 | 2.66% | 0.02% |
| Feb. 5, 2026 | GILLIS JONATHAN | CAAO and PAO | A | Employee Stock Option (right to buy) | 24455 | $0.00 | 24,455.0000 | 45,373,033 | 9999.99% | 0.05% |
| Feb. 5, 2026 | GILLIS JONATHAN | CAAO and PAO | A | Voting Common Stock | 6020 | $0.00 | 254,523.0000 | 45,373,033 | 2.42% | 0.01% |
| Feb. 5, 2026 | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 93955 | $0.00 | 93,955.0000 | 45,373,033 | 9999.99% | 0.21% |
| Feb. 5, 2026 | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 23145 | $0.00 | 1,750,941.0000 | 45,373,033 | 1.34% | 0.05% |
| Feb. 5, 2026 | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 31395 | $0.00 | 31,395.0000 | 45,373,033 | 9999.99% | 0.07% |
| Feb. 5, 2026 | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 54240 | $0.00 | 54,240.0000 | 45,373,033 | 9999.99% | 0.12% |
| Feb. 5, 2026 | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 13360 | $0.00 | 403,835.0000 | 45,373,033 | 3.42% | 0.03% |
| Feb. 5, 2026 | Hanson Kristopher | General Counsel | A | Employee Stock Option (right to buy) | 31395 | $0.00 | 31,395.0000 | 45,373,033 | 9999.99% | 0.07% |
| Feb. 5, 2026 | Hanson Kristopher | General Counsel | A | Voting Common Stock | 7730 | $0.00 | 191,582.0000 | 45,373,033 | 4.20% | 0.02% |
| Feb. 5, 2026 | Kreitzer Anatol | Chief Discovery Officer | A | Employee Stock Option (right to buy) | 24455 | $0.00 | 24,455.0000 | 45,373,033 | 9999.99% | 0.05% |
| Feb. 5, 2026 | Kreitzer Anatol | Chief Discovery Officer | A | Voting Common Stock | 6020 | $0.00 | 259,928.0000 | 45,373,033 | 2.37% | 0.01% |
| Feb. 5, 2026 | Setia Vishwas | Chief Financial Officer | A | Employee Stock Option (right to buy) | 31395 | $0.00 | 31,395.0000 | 45,373,033 | 9999.99% | 0.07% |
| Feb. 5, 2026 | Setia Vishwas | Chief Financial Officer | A | Voting Common Stock | 7730 | $0.00 | 395,549.0000 | 45,373,033 | 1.99% | 0.02% |
| Feb. 3, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 1 | $18.00 | 389,905.0000 | 45,373,033 | 0.00% | 0.00% |
| Feb. 2, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 7039 | $18.02 | 389,906.0000 | 45,373,033 | 1.77% | 0.02% |
| Jan. 28, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 5860 | $18.61 | 425,483.0000 | 45,373,033 | 1.36% | 0.01% |
| Jan. 30, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 6612 | $18.11 | 396,945.0000 | 45,373,033 | 1.64% | 0.01% |
| Jan. 29, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 21262 | $18.55 | 403,557.0000 | 45,373,033 | 5.00% | 0.05% |
| Jan. 28, 2026 | Malenka Robert C. | Not found | S | Voting Common Stock | 664 | $19.05 | 424,819.0000 | 45,373,033 | 0.16% | 0.00% |
| Jan. 27, 2026 | Foff Erin Pennock | Chief Medical Officer | F | Voting Common Stock | 44616 | $17.98 | 390,475.0000 | 45,373,033 | 10.25% | 0.10% |
| Jan. 27, 2026 | Hanson Kristopher | General Counsel | F | Voting Common Stock | 26007 | $17.98 | 183,852.0000 | 45,373,033 | 12.39% | 0.06% |
| Jan. 27, 2026 | GILLIS JONATHAN | CAAO and PAO | F | Voting Common Stock | 22050 | $17.98 | 248,503.0000 | 45,373,033 | 8.15% | 0.05% |
| Jan. 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | F | Voting Common Stock | 42099 | $17.98 | 253,908.0000 | 45,373,033 | 14.22% | 0.09% |
| Jan. 27, 2026 | Lillie James Woodruff | Chief Scientific Officer | F | Voting Common Stock | 45055 | $17.98 | 291,132.0000 | 45,373,033 | 13.40% | 0.10% |
| Jan. 27, 2026 | Setia Vishwas | Chief Financial Officer | F | Voting Common Stock | 33382 | $17.98 | 387,819.0000 | 45,373,033 | 7.93% | 0.07% |
| Jan. 27, 2026 | Kroeger Christopher A. | Chief Executive Officer | F | Voting Common Stock | 204146 | $17.98 | 1,727,796.0000 | 45,373,033 | 10.57% | 0.45% |
| Oct. 28, 2025 | Novo Holdings A/S | Not found | C | Voting Common Stock | 2733681 | $0.00 | 2,733,681.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2025 | Novo Holdings A/S | Not found | C | Series C Preferred Stock | 26191207 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Novo Holdings A/S | Not found | P | Voting Common Stock | 952941 | $17.00 | 3,686,622.0000 | 0 | 34.86% | 0.00% |
| Oct. 28, 2025 | Novo Holdings A/S | Not found | C | Series D Preferred Stock | 19734671 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series A Preferred Stock | 148809 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Voting Common Stock | 14256288 | $0.00 | 14,256,288.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series D Preferred Stock | 6678910 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series C Preferred Stock | 5444807 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series B-1 Preferred Stock | 275148 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series B Preferred Stock | 1263768 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | C | Series A-1 Preferred Stock | 444846 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 28, 2025 | Catalyst4, Inc. | Not found | P | Voting Common Stock | 5441176 | $17.00 | 19,697,464.0000 | 0 | 38.17% | 0.00% |
| Oct. 27, 2025 | Setia Vishwas | Chief Financial Officer | A | Employee Stock Option (right to buy) | 176031 | $0.00 | 176,031.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Lillie James Woodruff | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 132023 | $0.00 | 132,023.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Lillie James Woodruff | Chief Scientific Officer | A | Voting Common Stock | 32539 | $0.00 | 32,539.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Kreitzer Anatol | Chief Discovery Officer | A | Employee Stock Option (right to buy) | 146052 | $0.00 | 146,052.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Kreitzer Anatol | Chief Discovery Officer | A | Voting Common Stock | 35953 | $0.00 | 35,953.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | GILLIS JONATHAN | CAAO and PAO | A | Employee Stock Option (right to buy) | 124022 | $0.00 | 124,022.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | GILLIS JONATHAN | CAAO and PAO | A | Voting Common Stock | 30565 | $0.00 | 30,565.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Hanson Kristopher | General Counsel | A | Employee Stock Option (right to buy) | 110046 | $0.00 | 110,046.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Hanson Kristopher | General Counsel | A | Voting Common Stock | 27098 | $0.00 | 27,098.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Walker Maria C | Not found | A | Employee Stock Option (right to buy) | 25604 | $0.00 | 25,604.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Walker Maria C | Not found | A | Voting Common Stock | 6294 | $0.00 | 6,294.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Garnett Timothy John | Not found | A | Employee Stock Option (right to buy) | 25604 | $0.00 | 25,604.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2025 | Kroeger Christopher A. | Chief Executive Officer | C | Series C Preferred Stock | 65477 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 27, 2025 | Kroeger Christopher A. | Chief Executive Officer | A | Employee Stock Option (right to buy) | 916164 | $0.00 | 916,164.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2025 | Kroeger Christopher A. | Chief Executive Officer | C | Voting Common Stock | 3895 | $0.00 | 330,778.0000 | 0 | 1.19% | 0.00% |
| Oct. 27, 2025 | Kroeger Christopher A. | Chief Executive Officer | A | Voting Common Stock | 225693 | $0.00 | 326,883.0000 | 0 | 223.04% | 0.00% |
| Oct. 28, 2025 | Malenka Robert C. | Not found | C | Series C Preferred Stock | 65477 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 27, 2025 | Malenka Robert C. | Not found | A | Employee Stock Option (right to buy) | 139610 | $0.00 | 139,610.0000 | 0 | 9999.99% | 0.00% |
| Oct. 28, 2025 | Malenka Robert C. | Not found | C | Voting Common Stock | 3895 | $0.00 | 431,343.0000 | 0 | 0.91% | 0.00% |
| Oct. 27, 2025 | Malenka Robert C. | Not found | A | Voting Common Stock | 34390 | $0.00 | 431,343.0000 | 0 | 8.66% | 0.00% |
| Oct. 27, 2025 | Foff Erin Pennock | Chief Medical Officer | A | Employee Stock Option (right to buy) | 196035 | $0.00 | 196,035.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Garnett Timothy John | Not found | A | Voting Common Stock | 6294 | $0.00 | 6,294.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Foff Erin Pennock | Chief Medical Officer | A | Voting Common Stock | 48275 | $0.00 | 48,275.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | Setia Vishwas | Chief Financial Officer | A | Voting Common Stock | 43367 | $0.00 | 43,367.0000 | 0 | 9999.99% | 0.00% |